Skip to main content

Advertisement

Log in

About the specificity of radiotracers for prostate cancer

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schwenck J, Rempp H, Reischl G, Kruck S, Stenzl A, Nikolaou K, et al. Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT. Eur J Nucl Med Mol Imaging. 2017;44:92–101.

    Article  CAS  PubMed  Google Scholar 

  2. Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002;296:580–3.

    Article  CAS  PubMed  Google Scholar 

  3. Rietbergen DD, van der Hiel B, Vogel W, Stokkel MP. Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT. Nucl Med Commun. 2011;32:1143–7.

    Article  CAS  PubMed  Google Scholar 

  4. Golubic AT, Mutvar A, Zuvic M, Huic D. The nonspecific lymph node uptake of 18F-choline in patients with prostate cancer – a prospective observational study. Nucl Med Rev Cent East Eur. 2015;18:56–60.

    Article  PubMed  Google Scholar 

  5. Gu CN, Hunt CH, Lehman VT, Johnson GB, Diehn FE, Schwartz KM, et al. Benign fibrous dysplasia on [(11)C]choline PET: a potential mimicker of disease in patients with biochemical recurrence of prostate cancer. Ann Nucl Med. 2012;26:599–602.

    Article  CAS  PubMed  Google Scholar 

  6. Hofman MS, Iravani A. Gallium-68 prostate-specific membrane antigen PET imaging. PET Clin. 2017;12:219–34.

    Article  PubMed  Google Scholar 

  7. Chang SS, O’Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res. 1999;5:2674–81.

    CAS  PubMed  Google Scholar 

  8. Demirci E, Sahin OE, Ocak M, Akovali B, Nematyazar J, Kabasakal L. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging. Nucl Med Commun. 2016;37:1169–79.

    Article  CAS  PubMed  Google Scholar 

  9. Gykiere P, Goethals L, Everaert H. Healing sacral fracture masquerading as metastatic bone disease on a 68Ga-PSMA PET/CT. Clin Nucl Med. 2016;41:e346–7.

    Article  PubMed  Google Scholar 

  10. Sathekge M, Lengana T, Modiselle M, Vorster M, Zeevaart J, Maes A, et al. (68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients. Eur J Nucl Med Mol Imaging. 2017;44:689–94.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Soussan.

Ethics declarations

Conflicts of interest

None.

Ethical approval

This article does not describe any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soussan, M. About the specificity of radiotracers for prostate cancer. Eur J Nucl Med Mol Imaging 44, 2142–2143 (2017). https://doi.org/10.1007/s00259-017-3784-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-017-3784-3

Navigation